We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Gary C. Robb Joins Corcept as Chief Financial Officer
News

Gary C. Robb Joins Corcept as Chief Financial Officer

Gary C. Robb Joins Corcept as Chief Financial Officer
News

Gary C. Robb Joins Corcept as Chief Financial Officer

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Gary C. Robb Joins Corcept as Chief Financial Officer"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Corcept Therapeutics has announced the appointment of Gary C. ("Charlie") Robb to the position of Chief Financial Officer, effective September 1, 2011.

Mr. Robb will oversee Corcept's financial operations, including preparations for potential commercialization of our first product, business development activities, investor relations, and along with other members of the management team, corporate strategy.

"We are pleased to have a person with Charlie's financial and operational expertise join us at Corcept," said Joseph K. Belanoff, M.D., Chief Executive Officer of Corcept Therapeutics.

Belanoff continued, "Charlie's experience managing company finances and operations under rapid growth will be valuable to Corcept as we prepare to move CORLUX toward the market if our New Drug Application for Cushing's Syndrome is approved, continue our ongoing Phase 3 program for the treatment of the psychotic features of psychotic major depression and advance our second generation selective GR-II antagonists into clinical development."

Before joining Corcept, Mr. Robb served as Senior Vice President of Operations, Administration and Finance at Fitness Anywhere, Inc. (FAI), a private fitness equipment and training company with operations in the United States, Europe and Asia.

Mr. Robb's responsibilities at FAI included finance, legal affairs, human resources, management information systems, supply chain, distribution and logistics, and management of the intellectual property portfolio.

Mr. Robb has more than 25 years of experience in executive management, operations and finance.

From 2000 to 2002 he was Senior Vice President of Citadon, Inc., where he was founder of a division responsible for developing workflow and analytic software for real estate lenders with responsibilities including development of the division's strategy, marketing, budgeting, sales and mergers and acquisitions.

He has also held positions in business development for Normura Asset Capital Corporation and in sales and marketing for Legal Research Network, Inc. From 1992 to 1996 Mr. Robb practiced law at Howard, Rice, Nemerovski, Canady, Falk & Rabkin.

Mr. Robb earned a B.A. in English and Political Philosophy from Yale and a J.D. from Harvard Law School, where he was a member of the Harvard Law Review.

Advertisement